King & Spalding represented Novartis on the deal. The ECJ has ruled in a judgment of November 17, 2022 on the requests for preliminary rulings from...
King & Spalding represented Novartis on the deal. The ECJ has ruled in a judgment of November 17, 2022 on the requests for preliminary rulings from...
